Reversal of HIV Drug Resistance and Novel Strategies to Curb HIV Infection: The Viral Infectivity Factor Vif as a Target and Tool of Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|7|7|881-885

ISSN： 1389-4501

Source： Current Drug Targets, Vol.7, Iss.7, 2006-07, pp. : 881-885

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Viral Infectivity Factor: A Novel Therapeutic Strategy to Block HIV-1 Replication

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 7, 2013-06 ,pp. : 1047-1055

Bentham Science Publishers

Access to resources Recommend Favorite

Mathematical Approaches in the Study of Viral Kinetics and Drug Resistance in HIV-1 Infection

By  

Current Drug Targets - Infectious Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 329-344

Bentham Science Publishers

Access to resources Recommend Favorite

An In silico Approach for Identification of Novel Inhibitors as a Potential Therapeutics Targeting HIV-1 Viral Infectivity Factor

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 1, 2015-01 ,pp. : 65-72

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Anti-Viral Therapy: Drugs that Block HIV Entry at Different Target Sites

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 5, 2006-05 ,pp. : 557-562

Bentham Science Publishers

Access to resources Recommend Favorite

Lersivirine – a new drug for HIV infection therapy

By Platten Martin   Fätkenheuer Gerd  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 12, 2013-12 ,pp. : 1687-1694

Informa Healthcare

Access to resources Recommend Favorite